These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7040025)

  • 21. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood lidocaine levels and kinetics following high-dose intramuscular administration.
    Zener JC; Kerber RE; Spivack AP; Harrison DC
    Circulation; 1973 May; 47(5):984-8. PubMed ID: 4705587
    [No Abstract]   [Full Text] [Related]  

  • 23. Lidocaine prophylaxis in acute myocardial infarction.
    Noneman JW; Rogers JF
    Medicine (Baltimore); 1978 Nov; 57(6):501-15. PubMed ID: 362121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of intracoronary lidocaine on ventricular arrhythmia in the infarcted canine heart.
    Tordjman T; Raeder E; Lampert S; Lown B
    Pharmacotherapy; 1988; 8(5):295-8. PubMed ID: 3252195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of enhanced alpha-1-acid glycoprotein concentration on protein binding, pharmacokinetics and antiarrhythmic effect of lidocaine in the dog.
    De Rick AF; Belpaire FM; Dello C; Bogaert MG
    J Pharmacol Exp Ther; 1987 Apr; 241(1):289-93. PubMed ID: 3572791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
    Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
    Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy.
    Vaughan DP; Tucker GT
    Eur J Clin Pharmacol; 1976; 10(6):433-40. PubMed ID: 1001359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lidocaine and the quarternary ammonium compound QX-572 in acute myocardial infarction. A comparative study.
    Bergdahl B; Karlsson E; Magnusson JO; Sonnhag C
    Acta Med Scand; 1978; 204(4):311-4. PubMed ID: 358766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of duration of lidocaine infusion and route of cimetidine administration on lidocaine pharmacokinetics.
    Powell JR; Foster J; Patterson JH; Cross R; Wargin W
    Clin Pharm; 1986 Dec; 5(12):993-8. PubMed ID: 3802729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
    Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
    Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of intravenous lorcainide with lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized study with crossover option.
    Anderson JL; Anastasiou-Nana M; Lutz JR; Writer SL
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):333-41. PubMed ID: 3881497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the duration of infusion on the disposition of lidocaine in dogs.
    LeLorier J; Moisan R; Gagné J; Caillé G
    J Pharmacol Exp Ther; 1977 Dec; 203(3):507-11. PubMed ID: 925956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood levels of lidocaine after various infusion rates in patients with acute myocardial infarction.
    Rydén L; Waldenström A; Winsnes Y; Ortengren B
    Am Heart J; 1975 Apr; 89(4):470-3. PubMed ID: 1114978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lidocaine pharmacokinetics and substantiation of the new method of its administration in myocardial infarct].
    Piotrovskiĭ VK; Smirnova EB; Riabokon' OS; Mazur NA; Metelitsa VI
    Kardiologiia; 1979 Jul; 19(7):23-7. PubMed ID: 470315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic tocainide or lidocaine in acute myocardial infarction.
    Keefe DL; Williams S; Torres V; Flowers D; Somberg JC
    Am J Cardiol; 1986 Mar; 57(8):527-31. PubMed ID: 3082175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic lidocaine: concentrations in plasma and myocardial tissue and antifibrillatoric efficacy during early ischemia in dogs and pigs.
    Vogt B; Martin C; Meesmann W
    J Cardiovasc Pharmacol; 1988; 12(5):571-8. PubMed ID: 2468057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs.
    Krejcy K; Krumpl G; Todt H; Raberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):213-8. PubMed ID: 1448183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction.
    Koster RW; Dunning AJ
    N Engl J Med; 1985 Oct; 313(18):1105-10. PubMed ID: 3900727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifibrillatory and electrophysiologic actions of moricizine alone and in combination with lidocaine: a prospective, randomized trial.
    Ujhelyi MR; O'Rangers EA; Fan C; Kluger J; Chow MS
    Crit Care Med; 1993 Oct; 21(10):1577-84. PubMed ID: 8403970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.
    Sbarbaro JA; Rawling DA; Fozzard HA
    Am J Cardiol; 1979 Sep; 44(3):513-20. PubMed ID: 474432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.